Leo THOMAS;Rolf GREMPLER;Michael MARK;Peter EICKELMANN;Leo John SEMAN;Uli BROEDL
发明人:
Peter EICKELMANN,Michael MARK,Leo John SEMAN,Leo THOMAS,Uli BROEDL,Rolf GREMPLER
申请号:
US13439324
公开号:
US20120196812A1
申请日:
2012.04.04
申请国别(地区):
US
年份:
2012
代理人:
摘要:
The invention relates to the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia using a SGLT-2 inhibitor. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions.